About Mindspace Conferences
Mindspace Conferences is a dynamic and forward-thinking platform that unites a global community of scholars, researchers, students, and industry leaders to share knowledge, explore emerging trends, and foster collaboration across diverse scientific and professional fields. Hosting over 30 international conferences annually across multiple countries, Mindspace provides participants with exceptional opportunities to present their research, engage in meaningful dialogue, and connect with a worldwide audience.
Our platform is designed to encourage insightful discussions, collaborative brainstorming, and the exchange of innovative ideas that challenge current perspectives and highlight future developments. Each event features distinguished and accredited speakers who present the latest advancements, opportunities, and challenges within their domains, ensuring that every conference is both educational and inspiring.
Supported by agile technology, Mindspace Conferences seamlessly connects participants from varied backgrounds—including subject matter experts, researchers, and industry professionals—creating a vibrant, intellectually rich environment. This diversity enhances the depth and impact of each event, offering unique insights into cutting-edge research, emerging challenges, and key trends shaping global industries.
About Cancer & Oncology 2026:
Cancer & Oncology 2026 is the 3rd International Summit on Cancer & Oncology Research, organized by Mindspace Conferences, designed to bring together global experts, researchers, clinicians, and industry leaders in the fight against cancer. Scheduled for November 09–11, 2026, in Rome, Italy, this summit serves as a world-class platform to share groundbreaking research, innovative therapies, and emerging technologies that are shaping the future of oncology.
Under the theme “Breaking Boundaries. Defeating Cancer. Defining the Future,” Cancer & Oncology 2026 focuses on accelerating collaboration across disciplines, promoting knowledge exchange, and highlighting novel strategies in cancer prevention, diagnosis, and treatment. Through keynote presentations, interactive panels, workshops, and networking opportunities, participants will gain valuable insights, explore transformative solutions, and connect with a global community dedicated to advancing cancer care.
This summit is a must-attend event for oncologists, researchers, healthcare professionals, biotech and pharma experts, academics, and policymakers, offering an unparalleled opportunity to stay at the forefront of cancer research, discover emerging trends, and contribute to defining the future of oncology.
Featured Scientific Tracks:
Tumor Heterogeneity & Clonal Evolution
This session examines intra-tumor variability, clonal dynamics, and tumor evolution over time. It highlights insights from single-cell analyses and spatial mapping, emphasizing the implications of tumor heterogeneity for metastasis, therapy resistance, and personalized treatment strategies.
Metastasis & Invasion Biology
Focuses on the mechanisms by which tumors invade adjacent tissues and spread to distant organs. Key topics include epithelial-mesenchymal transition (EMT), angiogenesis, and the formation of metastatic niches that support tumor colonization.
Cancer Stem Cells
Explores tumor-initiating cells responsible for recurrence and therapy resistance. Sessions cover stemness regulation, cellular plasticity, and therapeutic strategies aimed at targeting these resilient cell populations.
Tumor Microenvironment & Immune Crosstalk
Examines the interactions between tumor cells, stromal components, and immune cells. Discussions focus on how the microenvironment influences tumor progression, immune evasion, and responses to therapy.
Epigenetics & Chromatin Regulation
Covers the role of DNA methylation, histone modifications, and chromatin remodeling in cancer. The focus is on how these epigenetic changes regulate gene expression, contribute to tumor progression, and affect therapy resistance.
Cancer Metabolism
Studies metabolic reprogramming in tumors, including alterations in glucose, lipid, and amino acid metabolism. It highlights potential metabolic vulnerabilities that can be targeted for therapy.
Early Cancer Detection & Screening
Explores strategies for identifying cancer at early, treatable stages. Topics include population-based screening programs, biomarker discovery, and advanced imaging techniques for early diagnosis.
Liquid Biopsy & Circulating Biomarkers
Focuses on non-invasive methods to detect tumor DNA, RNA, exosomes, and circulating tumor cells. These techniques are critical for early diagnosis, therapy monitoring, and minimal residual disease detection.
Precision Diagnostics & Molecular Profiling
Covers genomic, proteomic, and molecular profiling approaches to guide personalized cancer therapy. Sessions discuss companion diagnostics and predictive assays to tailor treatments to individual patients.
Imaging, Radiomics & Molecular Imaging
Highlights advanced imaging modalities, radiomic analysis, and molecular imaging techniques for accurate diagnosis, prognosis, and monitoring of therapy response.
Predictive & Prognostic Biomarkers
Identifies biomarkers that can predict therapeutic response or clinical outcomes. Discussions include validation methods and strategies for clinical implementation.
Immuno-Oncology & Checkpoint Inhibitors
Explores immune-based therapies, particularly checkpoint inhibitors, and strategies to enhance anti-tumor immunity while overcoming immune evasion mechanisms.
Targeted Cancer Therapies
Covers therapies aimed at specific molecular targets, including kinase inhibitors and other pathway-specific drugs. Focus is on precision oncology approaches to maximize treatment efficacy.
CAR-T Cell & Adoptive Cell Therapies
Focuses on chimeric antigen receptor (CAR) T cells, TCR-engineered cells, and other adoptive immune therapies. Includes discussions on clinical applications, safety, and resistance mechanisms.
Antibody-Drug Conjugates (ADCs)
Explores the development, mechanisms, and clinical applications of ADCs, highlighting the targeted delivery of cytotoxic agents via antibodies.
Cancer Vaccines & Immunotherapy Combinations
Focuses on therapeutic vaccines and combination approaches designed to enhance immunotherapy efficacy and patient outcomes.
Drug Resistance & Treatment Failure
Investigates the mechanisms underlying therapy resistance, including genetic, epigenetic, and microenvironmental factors that lead to treatment failure.
Combination & Multimodal Therapies
Covers strategies that combine chemotherapy, immunotherapy, targeted therapy, and radiotherapy to optimize patient outcomes and improve survival.
Translational Oncology
Bridges laboratory discoveries with clinical applications, emphasizing biomarker validation, novel drug testing, and early clinical trial design.
Artificial Intelligence & Machine Learning in Oncology
Explores AI-driven approaches for cancer diagnosis, prognosis, therapy selection, and predictive modeling, with the goal of improving clinical decision-making.
Bioinformatics & Cancer Big Data
Focuses on computational analysis of large-scale genomic, transcriptomic, proteomic, and clinical datasets to identify trends, targets, and insights in oncology research.
Single-Cell & Spatial Omics
Covers single-cell sequencing and spatial omics approaches to study tumor heterogeneity, cellular interactions, and microenvironment architecture at high resolution.
Multi-Omics Data Integration
Integrates genomics, transcriptomics, proteomics, and metabolomics data to provide a holistic understanding of tumors and identify novel therapeutic targets.
Predictive Oncology & Risk Modeling
Develops predictive models to forecast disease progression, therapy response, and patient-specific risks using clinical and molecular data.
Cancer Type-Specific Research
Organ-specific sessions integrating biology, translational research, and clinical advances for each tumor type.
Lung & Thoracic Oncology
Focuses on lung cancers and thoracic malignancies, including advances in targeted therapy, immunotherapy, and early detection strategies.
Hematologic Malignancies
Covers leukemia, lymphoma, multiple myeloma, and cellular therapies, emphasizing translational research and clinical applications.
Rare Cancers & Orphan Tumors
Highlights sarcomas, neuroendocrine tumors, thymomas, and other rare cancers, focusing on research, clinical management, and therapeutic strategies.
Comprehensive Cancer Care: Integrating Treatment and Prevention
This session provides an in-depth overview of modern cancer care, combining the latest treatment strategies with practical prevention approaches.
Relevant Keywords for Cancer & Oncology Conferences:
Cancer meetings |Oncology conferences |Cancer research conferences |Tumor biology conferences | Cancer therapy conferences | Cancer science conferences | Cancer symposiums | Cancer workshops| Cancer forums |Cancer congress| Cancer summits |Cancer seminars| Cancer retreats| Cancer events |Cancer lectures| Cancer roundtables| Cancer panels| Cancer colloquiums| Cancer think tanks| Tumor conferences |Cancer research| Meetings Oncology symposiums| Tumor biology meetings| Cancer therapy meetings| Cancer science meetings |Oncology workshops |Oncology congresses |Oncology seminars |Oncology events |Oncology roundtables |Oncology colloquiums Radiology conference| Imaging congress |Radiologic imaging conference |Diagnostic imaging congress | Medical imaging conference |Radiography congress Radiology |symposium Radiology meeting| Radiology colloquium |Radiology forum| Radiology workshop |Tumor colloquiums |Radiology seminar| Radiology convention| Radiology exhibition |Oncology research events |Cancer science events |Tumor board conferences| Tumor meetings | World Cancer Congress | Congress of Radiology |